310
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pazopanib: therapeutic developments

& , MD
Pages 3091-3102 | Published online: 02 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Carmen Criscitiello, Lucia Gelao, Giulia Viale, Angela Esposito & Giuseppe Curigliano. (2014) Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy. Expert Opinion on Investigational Drugs 23:5, pages 599-610.
Read now
Brian Rini & Mhd Yaser Al-Marrawi. (2011) Pazopanib for the treatment of renal cancer. Expert Opinion on Pharmacotherapy 12:7, pages 1171-1189.
Read now
Elena Geuna, Andrea Milani, Stefania Redana, Valentina Rossi, Giorgio Valabrega, Massimo Aglietta & Filippo Montemurro. (2011) Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?. Expert Opinion on Pharmacotherapy 12:4, pages 549-565.
Read now
Peter E Clark. (2010) Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma. Biologics: Targets and Therapy 4, pages 187-197.
Read now

Articles from other publishers (17)

Ping Yu, Yaru Wang, Dahai Yuan, Yunqin Sun, Shuang Qin & Tianye Li. (2023) Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. Frontiers in Immunology 14.
Crossref
Hong-yang Sun, Jin Wu, Rui Wang, Shun Zhang, Hao Xu, Еlena Kaznacheyeva, Xiao-jun Lu, Hai-gang Ren & Guang-hui Wang. (2022) Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway. Acta Pharmacologica Sinica 44:6, pages 1135-1148.
Crossref
Paul Dent. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 250 261 .
Jun Akatsuka, Go Kimura, Kotaro Obayashi, Kotaro Tsutsumi, Masato Yanagi, Yuki Endo, Hayato Takeda, Tatsuro Hayashi, Yuka Toyama, Yasutomo Suzuki, Tsutomu Hamasaki, Yoichiro Yamamoto & Yukihiro Kondo. (2021) Outcomes of starting low-dose pazopanib in patients with metastatic renal cell carcinoma who do not meet eligibility criteria for clinical trials. Urological Science 32:3, pages 104.
Crossref
Paul Dent. 2021. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 237 283 .
Lingling Zhang, Huanan Wang, Wei Li, Juchang Zhong, Rongcheng Yu, Xinfeng Huang, Honghui Wang, Zhikai Tan, Jiangang Wang & Yingjie Zhang. (2016) Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis. Oncotarget 8:2, pages 3289-3303.
Crossref
Yuping Jia, Jian Zhang, Jinhong Feng, Fuming Xu, Huili Pan & Wenfang Xu. (2014) Design, Synthesis and Biological Evaluation of Pazopanib Derivatives as Antitumor Agents. Chemical Biology & Drug Design 83:3, pages 306-316.
Crossref
Dana Faingold, Silvin Bakalian & Dawn S. Russell-Hermanns. 2013. Experimental and Clinical Metastasis. Experimental and Clinical Metastasis 445 469 .
Amy M. Pick & Kelly K. Nystrom. (2012) Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma. Clinical Therapeutics 34:3, pages 511-520.
Crossref
Alexander Kutikov, Peter Makhov, Konstantin Golovine, Daniel J. Canter, Mohit Sirohi, Ryan Street, Jay Simhan, Robert G. Uzzo & Vladimir M. Kolenko. (2011) Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer. Urology 78:4, pages 968.e7-968.e11.
Crossref
Sushil Kumar, Reza Bayat Mokhtari, Reihaneh Sheikh, Bing Wu, Libo Zhang, Ping Xu, Shan Man, Indhira Dias Oliveira, Herman Yeger, Robert S. Kerbel & Sylvain Baruchel. (2011) Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor. Clinical Cancer Research 17:17, pages 5656-5667.
Crossref
Michael R. Harrison. (2011) Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?. Clinical Medicine Insights: Oncology 5, pages CMO.S6087.
Crossref
Brunilde Gril, Diane Palmieri, Yong Qian, DeeDee Smart, Lilia Ileva, David J. Liewehr, Seth M. Steinberg & Patricia S. Steeg. (2011) Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis. Clinical Cancer Research 17:1, pages 142-153.
Crossref
Ioannis S. Vizirianakis, Maria Chatzopoulou, Ioannis D. Bonovolias, Ioannis Nicolaou, Vassilis J. Demopoulos & Asterios S. Tsiftsoglou. (2010) Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. Journal of Medicinal Chemistry 53:19, pages 6779-6810.
Crossref
Joshua M. LangMichael R. Harrison. (2010) Pazopanib for the Treatment of Patients with Advanced Renal Cell Carcinoma. Clinical Medicine Insights: Oncology 4, pages CMO.S4088.
Crossref
Shridhar Hegde & Michelle Schmidt. 2010. 466 537 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.